Although enhanced microvascular GLUT1 did not restore ATP levels, it resulted in altered metabolic profiles with some neuroactive metabolites being improved, which may have contributed to mitigating postoperative cognitive impairment. The gene discussed is SLC2A1; the disease is Cognitive impairment.